Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FSHD1”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Large-scale testing (Phase 3)Looking for participantsNCT07038200
What this trial is testing

Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

Who this might be right for
Facioscapulohumeral Muscular DystrophyFSHDFSHD - Facioscapulohumeral Muscular Dystrophy+14 more
Avidity Biosciences, Inc. 200
Not applicableLooking for participantsNCT07409142
What this trial is testing

BetterLife FSHD: A Patient-driven Health and Research Platform

Who this might be right for
FSHFSH Muscular DystrophyFSHD - Facioscapulohumeral Muscular Dystrophy+8 more
FSHD Society 5,000
Not applicableStudy completedNCT02032979
What this trial is testing

Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2

Who this might be right for
Muscular Dystrophy, Facioscapulohumeral
Centre Hospitalier Universitaire de Nice 6
Testing effectiveness (Phase 2)Ended earlyNCT04264442
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 76
Testing effectiveness (Phase 2)Ended earlyNCT04004000
What this trial is testing

Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Fulcrum Therapeutics 14
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06547216
What this trial is testing

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 84
Not applicableLooking for participantsNCT04369209
What this trial is testing

A Registered Cohort Study on FSHD1

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
Ning Wang, MD., PhD. 1,000
Not applicableLooking for participantsNCT06911190
What this trial is testing

Ten Year Follow-up in FSHD: the FOCUS 3 Study

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Radboud University Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT04003974
What this trial is testing

Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 80
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Not applicableLooking for participantsNCT06078852
What this trial is testing

Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients

Who this might be right for
FSHD1FSHD2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 34
Not applicableStudy completedNCT02159612
What this trial is testing

1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Grete Andersen, MD 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05747924
What this trial is testing

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 90
Large-scale testing (Phase 3)Ended earlyNCT05397470
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 260
Not applicableStudy completedNCT07331025
What this trial is testing

Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings

Who this might be right for
Facioscapulohumeral Muscular DystrophyFacioscapulohumeral Muscular Dystrophy 1Neuromuscular Disease
Koç University 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT06222827
What this trial is testing

Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Centre Hospitalier Universitaire de Nice 46
Not applicableUnknownNCT05295277
What this trial is testing

Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort

Who this might be right for
Developmental DisabilityIntellectual DisabilityAutism Spectrum Disorder+3 more
Bionano Genomics 1,000
Not applicableStudy completedNCT02948244
What this trial is testing

Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD

Who this might be right for
Facio-Scapulo-Humeral DystrophyFSHD2FSHD1
Murdoch Childrens Research Institute 11